Delving Into Participation Trends in Renal Cell Carcinoma Studies
Not yet recruiting
- Conditions
- Renal Cell Carcinoma
- Registration Number
- NCT06093568
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
The study seeks to delve into the firsthand experiences of patients diagnosed with renal cell carcinoma who partake in a separate clinical study featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals.
By joining this clinical trial, individuals have the unique opportunity to contribute to the betterment of future renal cell carcinoma patients and play an active role in advancing clinical research.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Patient has been diagnosed with renal cell carcinoma
- Patient is a minimum of 18 years or older
- Patient has self-identified as planning to enroll in a clinical study
Exclusion Criteria
- Patient does not understand, sign, and return consent form
- Inability to perform regular electronic reporting
- Patient is pregnant
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Number of patients who decide to participate in a renal cell carcinoma clinical study 3 months Rate of patients who remain in renal cell carcinoma clinical trial to trial completion 12 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Power Life Sciences
🇺🇸San Francisco, California, United States